RCT of an Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to "Stay Within the Guidelines" (SUSTAIN)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Stroke
- Sponsor
- University of California, Los Angeles
- Enrollment
- 410
- Locations
- 5
- Primary Endpoint
- Blood Pressure
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this study is to test a newly developed outpatient care intervention called SUSTAIN (Systematic Use of Stroke Averting Interventions) for improving delivery of stroke preventive services at Los Angeles County hospitals and to measure the costs of running such an intervention.
Detailed Description
Patients randomized to SUSTAIN will participate in group clinics about stroke, given self-management tools about stroke, and will be called by nurse practitioners to coordinate their stroke care. Patients randomized to the control arm will be mailed educational materials about stroke. Subjects in either arm are eligible to receive their usual source of care.
Investigators
Barbara Vickrey, MD, MPH
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
Inclusion Criteria
- •Patients of LAC+USC, Rancho Los Amigos, Olive View-UCLA, or Harbor-UCLA
- •Patients who have had an acute transient ischemic attack (TIA) or ischemic stroke or carotid procedure within the last six months
- •English or Spanish speaking
- •At least 40 years of age
- •Capable of giving informed consent (no proxies will be used to obtain consent)
- •Blood pressure not optimally controlled (\>120/80, at least 72 hours post-stroke)
Exclusion Criteria
- •Age 39 years or younger
- •Hemorrhagic stroke
- •Patients with severe global disability which would preclude him/her from participating in group clinics
- •Patients with advanced dementia
Outcomes
Primary Outcomes
Blood Pressure
Time Frame: 12 months
Blood pressure at 12 months will be the primary outcome. Blood pressure will also be measured at baseline and at the 3-month mark to track blood pressure during the entire participation period.
Secondary Outcomes
- Lipid levels(12 month)
- Medication Adherence(8 months)